The dawning of a new age of toxicology (original) (raw)
Authors
- Marcel Leist Doerenkamp-Zbinden Chair for alternative in vitro methods, University of Konstanz, Germany
- Thomas Hartung ECVAM/ IHCP, EC-Joint Research Centre, Ispra, Italy
- Pierluigi Nicotera MRC Toxicology Unit, University of Leicester, Leicester, UK
DOI:
https://doi.org/10.14573/altex.2008.2.103
Keywords:
in vitro toxicology, REACH, toxicity pathways, environmental agents
Abstract
Toxicology faces enormous challenges in a world in which we are exposed to thousands of chemicals and millions of mixtures thereof. Radically new approaches to this problem need to be developed. A milestone in this direction is the vision of the US National Research Council (NRC) “Toxicity testing in the 21st century: a Vision and a Strategyˮ. Currently, an alliance formed by the National Toxicology Program (NTP) and the Chemical Genomics Centre (NCGC) of the National Institutes of Health (NIH) and the Computational Toxicology Centre (NCCT) of the Environmental Protection Agency (EPA) is testing whether this new strategy can realistically form the basis of future public health decisions. The vision requires a radical paradigm shift in the approach to safety assessments, and turns the traditional procedures upside down. Where animal experiments used to be the most important technology, the future is seen in the strength of in vitro and in silico approaches based on human material. Todayʼs toxicity testing starts with an initial black box screen on animals, sometimes followed by mechanistic studies, while the new vision approaches hazard assessment bottom-up. The procedure would begin with in vitro tests to define the affected pathways. To fill remaining gaps of knowledge, limited and targeted testing in animals would then be performed as a possible second step. This means nothing less than changing toxicology from being a predominantly observational craft and regulatory support discipline back to a natural science with all its dimensions. The background and the implications are discussed here in particular for a readership with interest also in parallel European trends.
License
Copyright (c) 2008 The author(s)
This work is licensed under a Creative Commons Attribution 4.0 International License.
Articles are distributed under the terms of the Creative Commons Attribution 4.0 International license (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium, provided the original work is appropriately cited (CC-BY). Copyright on any article in ALTEX is retained by the author(s).
How to Cite
“The dawning of a new age of toxicology” (2008) ALTEX - Alternatives to Animal Experimentation, 25(2), pp. 103–114. doi:10.14573/altex.2008.2.103.
Most read articles by the same author(s)
- Lucy Meigs, Lena Smirnova, Costanza Rovida, Marcel Leist, Thomas Hartung, Animal testing and its alternatives – the most important omics is economics, ALTEX - Alternatives to Animal Experimentation: Vol. 35 No. 3 (2018)
- David Pamies, Marcel Leist, Sandra Coecke, Gerard Bowe, David G. Allen, Gerhard Gstraunthaler, Anna Bal-Price, Francesca Pistollato, Rob B. M. de Vries, Helena T. Hogberg, Thomas Hartung, Glyn Stacey, Guidance document on Good Cell and Tissue Culture Practice 2.0 (GCCP 2.0), ALTEX - Alternatives to Animal Experimentation: Vol. 39 No. 1 (2022)
- Thomas Hartung, Phasing in human-relevant science: Why the UK’s roadmap matters – and how to make it work, ALTEX - Alternatives to Animal Experimentation: Vol. 43 No. 1 (2026)
- Marcel Leist, Silvia Tangianu, Femke Affourtit, Hedwig Braakhuis, John Colbourne, Eike Cöllen, Nadine Dreser, Sylvia E. Escher, Iain Gardner, Stefan Hahn, Barry Hardy, Matthias Herzler, Barira Islam, Hennicke Kamp, Viktoria Magel, Philip Marx-Stoelting, Martijn J. Moné, Patrik Lundquist, Ilse Ottenbros, Gladys Ouedraogo, Giorgia Pallocca, Bob van de Water, Mathieu Vinken, Andrew White, Manuel Pastor, Mirjam Luijten, An Alternative Safety Profiling Algorithm (ASPA) to transform next generation risk assessment into a structured and transparent process, ALTEX - Alternatives to Animal Experimentation: Vol. 43 No. 1 (2026)
- Thomas Hartung, Nicole Kleinstreuer, Challenges and opportunities for validation of AI-based new approach methods, ALTEX - Alternatives to Animal Experimentation: Vol. 42 No. 1 (2025)
- Ronit Mohapatra, Marcel Leist, Sonja von Aulock, Thomas Hartung, Guidance for Good In Vitro Reporting Standards (GIVReSt) – A draft for stakeholder discussion and background documentation, ALTEX - Alternatives to Animal Experimentation: Vol. 42 No. 3 (2025)
- Anja Henn, Søren Lund, Maj Hedtjärn, André Schrattenholz, Peter Pörzgen, Marcel Leist, The suitability of BV2 cells as alternative model system for primary microglia cultures or for animal experiments examining brain inflammation, ALTEX - Alternatives to Animal Experimentation: Vol. 26 No. 2 (2009)
- Thomas Hartung, Lena Smirnova, Stefan Platz, Ivano Amelio, Marcel Leist, The need for epigenotoxicity testing, ALTEX - Alternatives to Animal Experimentation: Vol. 42 No. 4 (2025)
- Uwe Marx, Takafumi Akabane, Tommy B. Andersson, Elizabeth Baker, Mario Beilmann, Sonja Beken, Susanne Brendler-Schwaab, Murat Cirit, Rhiannon David, Eva-Maria Dehne, Isabell Durieux, Lorna Ewart, Suzanne C. Fitzpatrick, Olivier Frey, Florian Fuchs, Linda G. Griffith, Geraldine A. Hamilton, Thomas Hartung, Julia Hoeng, Helena Hogberg, David J. Hughes, Donald E. Ingber, Anita Iskandar, Toshiyuki Kanamori, Hajime Kojima, Jochen Kuehnl, Marcel Leist, Bo Li, Peter Loskill, Donna L. Mendrick, Thomas Neumann, Giorgia Pallocca, Ivan Rusyn, Lena Smirnova, Thomas Steger-Hartmann, Danilo A. Tagle, Alexander Tonevitsky, Sergej Tsyb, Martin Trapecar, Bob van de Water, Janny van den Eijnden-van Raaij, Paul Vulto, Kengo Watanabe, Armin Wolf, Xiaobing Zhou, Adrian Roth, Biology-inspired microphysiological systems to advance patient benefit and animal welfare in drug development, ALTEX - Alternatives to Animal Experimentation: Vol. 37 No. 3 (2020)
- Jean Knight, Costanza Rovida, Reinhard Kreiling, Cathy Zhu, Mette Knudsen, Thomas Hartung, Continuing animal tests on cosmetic ingredients for REACH in the EU, ALTEX - Alternatives to Animal Experimentation: Vol. 38 No. 4 (2021)
